As the evidence of the last ten years clearly shows, embryonic stem cell research is a dead end. Despite the constant hype of the MSM and others, ESCR has produced no cures, no helpful treatments, and no promising hopes of real breakthroughs. But the development of medical treatments using adult stem cells? That's where the results have come through -- over and over.
But even if the media refuses to tell the truth about the remarkable successes being developed using cord blood cells, skin cells etc., there are others who are becoming keenly aware that the smart money is on adult stem cell research. Here is another case of a company who is following that smart money in a literal way.
And in a related story, here's a newspaper in Australia describing a major new government investment in adult stem cell research.
Leave a comment